Phono-Motor Therapy + Semantic Feature Analysis for Dyslexia

(AMT Trial)

Not yet recruiting at 2 trial locations
WW
OB
Overseen ByOlga Boukrina, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two types of therapy to determine which better aids reading difficulties caused by a stroke. Participants will receive either phono-motor therapy, which focuses on sounds and speech movements, or semantic feature analysis, which emphasizes understanding word meanings. The goal is to determine if matching the therapy to a person's specific type of reading impairment proves more effective. This trial suits those who had a stroke and now struggle with reading, provided they were fluent in English before the stroke and can still see and hear well. Participants will follow a thorough treatment schedule, with therapy sessions spread over several weeks. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could tailor therapies to individual needs.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that Phono-Motor Therapy (PMT) is generally well-tolerated. One study found it improves the use of sounds in language and enhances oral reading skills. No serious side effects were reported, suggesting safety for individuals with reading difficulties.

Semantic Feature Analysis (SFA) is also considered safe. Studies have demonstrated that it improves vocabulary and reading comprehension without major side effects. It has been successfully used with both children and adults.

Both treatments have shown positive results in past studies, indicating they are safe and could benefit individuals with dyslexia. Participants typically handle these therapies well.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it combines Phono-Motor Therapy and Semantic Feature Analysis in a way that is tailored to each individual's specific type of dyslexia. Unlike standard treatments that often use a one-size-fits-all approach, this trial uses computational modeling to predict the most effective therapy for each person's unique reading challenges. This personalized approach could lead to more effective and faster improvements in reading skills, making it a promising avenue for individuals with acquired dyslexia. By focusing on both phonological and semantic aspects of language processing, the trial aims to address the root causes of reading impairments more comprehensively than existing therapies.

What evidence suggests that this trial's treatments could be effective for dyslexia?

Research shows that phono-motor therapy (PMT) can enhance sound processing and reading aloud. Some studies suggest PMT might outperform other methods for those with language difficulties. However, not everyone experiences improved reading comprehension, though some individuals do benefit. In this trial, participants in the model-matched group may receive PMT if it aligns with their computational model prediction.

Semantic Feature Analysis (SFA) has successfully helped individuals with language impairments improve their ability to name objects and ideas. Studies consistently show positive results, indicating that SFA can enhance naming skills. Participants in the model-matched group may receive SFA if it matches their computational model prediction. Both therapies target different areas but have shown promise in addressing specific language challenges.13678

Who Is on the Research Team?

WW

William W Graves, PhD

Principal Investigator

Rutgers, The State University of New Jersey

Are You a Good Fit for This Trial?

This trial is for individuals who have developed dyslexia following a stroke. Participants should be willing to undergo two full rounds of cognitive therapy treatments, each lasting 60 hours over several weeks.

Inclusion Criteria

My vision is normal or corrected to normal.
I can hear normally or with hearing aids.
Impaired reading as confirmed by significant impairment in the Basic Skills cluster of the Woodcock Reading Mastery Test - III
See 2 more

Exclusion Criteria

I have a neurological condition affecting my brain, not caused by a left hemisphere stroke.
Severe apraxia of speech (determined by consensus judgment among speech-language pathologists)
Inability to undergo, or provide a copy of, a post-stroke brain imaging scan
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment Round 1

Participants receive either phonomotor treatment (PMT) or semantic feature analysis (SFA) for 60 hours, distributed over 5 days a week for 2 hours a day

6 weeks

Treatment Round 2

Participants receive the alternative therapy for another 60 hours, distributed over 5 days a week for 2 hours a day

6 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Acquired Dyslexia Modeling and Treatment
  • Phono-Motor Therapy
  • Semantic Feature Analysis
Trial Overview The study tests two types of cognitive therapies: Phono-Motor Therapy (PMT) and Semantic Feature Analysis (SFA). Each participant will receive both treatments in separate rounds to compare their effectiveness based on a computational model's predictions.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Model-matchedExperimental Treatment2 Interventions
Group II: Model-non-matchedActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/24686537/
Effects of intensive phonomotor treatment on reading in ...No group improvement was found for reading comprehension; however, one individual did show improvement immediately post- and 3-months posttreatment. Conclusions ...
Effects of Intensive Phonomotor Treatment on Reading in ...Reading treatments targeting phonological processing and awareness have shown to be effective not only for children with developmental dyslexia. (Alexander et ...
Effects of Intensive Phonomotor Treatment on Reading in ...This study provides support that phonomotor treatment is a viable approach to improve phonological processing and oral reading for PWA with phonological alexia.
The Phonomotor Approach to Treating Phonological-Based ...Results on impairment-level outcome measures showed that treatment and generalization effects in the phonomotor treatment group were supe- rior to those of ...
Effects of Intensive Phonomotor Treatment on Reading in ...No group improvement was found for reading comprehension; however, one individual did show improvement immediately post- and 3-months ...
Effects of Phonomotor Therapy and Semantic Feature ...This study was undertaken to further investigate the question of whether treatment of word retrieval problems in aphasia, which are ubiquitous and, therefore, a ...
Improving reading competence in aphasia with combined ...Each treatment session will be video recorded, with at least two videos per week randomly selected for fidelity checks, ensuring. 20% of ...
Rapid Syllable Transition Treatment—A ...The treatment uses nonwords to help children build and store accurate motor plans and programs using principles of motor learning. Treatment ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security